Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Related articles

Arrhythmia in athletes

INTRODUCTION

Arrhythmias are not infrequently documented in athletes and can be a source of morbidity and mortality, particularly ventricular tachyarrhythmias leading to sudden cardiac death (SCD). It is therefore important to establish guidelines for screening of athletes with two goals in mind:

To document the presence of arrhythmia and underlying structural heart disease that place the athlete at risk for sudden death.

To evaluate the importance of an arrhythmia in assessing the athlete's eligibility for competition.

This topic will discuss specific arrhythmias or arrhythmia-related syndromes and their importance in athletes. The risk is related to the intensity and type of exercise (figure 1) [1]. The risk of sudden death in athletes, particularly those with underlying heart disease, the approach to screening to prevent sudden death in athletes, and the management of conduction disturbances in athletes are discussed elsewhere. (See "Risk of sudden cardiac death in athletes" and "Electrocardiographic abnormalities and conduction disturbances in athletes" and "Screening to prevent sudden cardiac death in athletes".)

SYNCOPE

Syncope in an athlete is an important symptom that requires a thorough evaluation. A common cause of syncope in young athletes is neurally mediated (vasovagal) syncope, which is generally unassociated with cardiac disease [2-5]. This type of syncope is due to neurally mediated mechanisms, but hypovolemia from unreplaced fluid losses may contribute in athletes. Athletes (especially those engaged in endurance disciplines) may also be more susceptible to neurally mediated syncope by nature of their increased vagal tone [6]. (See "Pathogenesis and etiology of syncope".)

                        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2014. | This topic last updated: Jan 9, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Mitchell JH, Haskell W, Snell P, Van Camp SP. Task Force 8: classification of sports. J Am Coll Cardiol 2005; 45:1364.
  2. Sakaguchi S, Shultz JJ, Remole SC, et al. Syncope associated with exercise, a manifestation of neurally mediated syncope. Am J Cardiol 1995; 75:476.
  3. Colivicchi F, Ammirati F, Biffi A, et al. Exercise-related syncope in young competitive athletes without evidence of structural heart disease. Clinical presentation and long-term outcome. Eur Heart J 2002; 23:1125.
  4. Colivicchi F, Ammirati F, Santini M. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J 2004; 25:1749.
  5. Calkins H, Seifert M, Morady F. Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope. Am Heart J 1995; 129:1159.
  6. Hastings JL, Levine BD. Syncope in the athletic patient. Prog Cardiovasc Dis 2012; 54:438.
  7. Zipes DP, Ackerman MJ, Estes NA 3rd, et al. Task Force 7: arrhythmias. J Am Coll Cardiol 2005; 45:1354.
  8. Talan DA, Bauernfeind RA, Ashley WW, et al. Twenty-four hour continuous ECG recordings in long-distance runners. Chest 1982; 82:19.
  9. Abdon NJ, Landin K, Johansson BW. Athlete's bradycardia as an embolising disorder? Symptomatic arrhythmias in patients aged less than 50 years. Br Heart J 1984; 52:660.
  10. Stein R, Medeiros CM, Rosito GA, et al. Intrinsic sinus and atrioventricular node electrophysiologic adaptations in endurance athletes. J Am Coll Cardiol 2002; 39:1033.
  11. Bjørnstad H, Storstein L, Meen HD, Hals O. Ambulatory electrocardiographic findings in top athletes, athletic students and control subjects. Cardiology 1994; 84:42.
  12. Wang YG, Mariman RJ, Wilbur DJ, et al. Various electrocardiographic and electrophysiologic presentations of normal and abnormal sinus node. J Cardiovasc Electrophysiol 1992; 3:187.
  13. Munger TM, Packer DL, Hammill SC, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989. Circulation 1993; 87:866.
  14. Furlanello F, Bertoldi A, Bettini R, et al. Life-threatening tachyarrhythmias in athletes. Pacing Clin Electrophysiol 1992; 15:1403.
  15. Klein GJ, Yee R, Sharma AD. Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med 1989; 320:1229.
  16. Zehender M, Meinertz T, Keul J, Just H. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J 1990; 119:1378.
  17. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002; 40:446.
  18. Biffi A, Maron BJ, Verdile L, et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2004; 44:1053.